Ravinder S Saini, Muhammad Ali Abdullah Almoyad, Rayan Ibrahim H Binduhayyim, Syed Altafuddin Quadri, Vishwanath Gurumurthy, Shashit Shetty Bavabeedu, Mohammed Saheer Kuruniyan, Punnoth Poonkuzhi Naseef, Seyed Ali Mosaddad, Artak Heboyan
OBJECTIVE: The current body of research on utilizing botulinum toxin (BTX) to manage temporomandibular disorders (TMDs) has not yet yielded definitive conclusions. The primary objective of this study was to determine the effectiveness of BTX in pain reduction for TMDs compared to placebo and other treatments. The secondary outcomes evaluated were adverse events, maximum mouth opening, bruxism events, and maximum occlusal force. MATERIALS AND METHODS: A literature search was performed on PubMed, Dimension Publication, Scopus, and Google Scholar...
2024: PloS One